"Antiviral Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.
| Descriptor ID |
D000998
|
| MeSH Number(s) |
D27.505.954.122.388
|
| Concept/Terms |
Antiviral Agents- Antiviral Agents
- Agents, Antiviral
- Antivirals
- Antiviral Drugs
- Drugs, Antiviral
|
Below are MeSH descriptors whose meaning is more general than "Antiviral Agents".
Below are MeSH descriptors whose meaning is more specific than "Antiviral Agents".
This graph shows the total number of publications written about "Antiviral Agents" by people in this website by year, and whether "Antiviral Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 0 | 1 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 2 | 0 | 2 |
| 1999 | 2 | 1 | 3 |
| 2000 | 1 | 0 | 1 |
| 2001 | 2 | 1 | 3 |
| 2002 | 1 | 2 | 3 |
| 2003 | 4 | 3 | 7 |
| 2004 | 0 | 2 | 2 |
| 2005 | 1 | 1 | 2 |
| 2006 | 3 | 0 | 3 |
| 2007 | 2 | 1 | 3 |
| 2008 | 6 | 2 | 8 |
| 2009 | 3 | 0 | 3 |
| 2010 | 6 | 1 | 7 |
| 2011 | 5 | 1 | 6 |
| 2012 | 4 | 2 | 6 |
| 2013 | 4 | 2 | 6 |
| 2014 | 3 | 2 | 5 |
| 2015 | 6 | 2 | 8 |
| 2016 | 8 | 1 | 9 |
| 2017 | 4 | 0 | 4 |
| 2018 | 3 | 0 | 3 |
| 2019 | 4 | 3 | 7 |
| 2020 | 3 | 3 | 6 |
| 2021 | 2 | 3 | 5 |
| 2022 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antiviral Agents" by people in Profiles.
-
Monkeypox: A focused narrative review for emergency medicine clinicians. Am J Emerg Med. 2022 Nov; 61:34-43.
-
Real-World Treatment Patterns of Antiviral Prophylaxis for Cytomegalovirus Among Adult Kidney Transplant Recipients: A Linked USRDS-Medicare Database Study. Transpl Int. 2022; 35:10528.
-
Cocaine Self-Administration Influences Central Nervous System Immune Responses in Male HIV-1 Transgenic Rats. Cells. 2022 08 04; 11(15).
-
De novo emergence of SARS-CoV-2 spike mutations in immunosuppressed patients. Transpl Infect Dis. 2022 Dec; 24(6):e13914.
-
Clinical update on COVID-19 for the emergency and critical care clinician: Medical management. Am J Emerg Med. 2022 Jun; 56:158-170.
-
Epidemiology and Clinical Characteristics of Individuals with Hepatitis C Virus Infection in the United States, 2017-2019. Adv Ther. 2021 12; 38(12):5777-5790.
-
Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls. Rheumatol Int. 2022 03; 42(3):457-467.
-
Just the facts: updates in COVID-19 therapeutics. CJEM. 2021 May; 23(3):283-285.
-
Patient-reported outcomes 12?months after hepatitis C treatment with direct-acting antivirals: Results from the PROP UP study. Liver Int. 2021 04; 41(4):692-704.
-
Potential Antiviral Immune Response Against COVID-19: Lessons Learned from SARS-CoV. Adv Exp Med Biol. 2021; 1318:149-167.